FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936758797> ?p ?o ?g. }

• W2936758797 endingPage "2766" @default.
• W2936758797 startingPage "2751" @default.
• W2936758797 abstract "To evaluate the efficacy and safety of rituximab-based combination therapy for Waldenström macroglobulinemia (WM), we conducted this meta-analysis by pooling the rates of overall response, major response, complete response, and grade ≥3 hematological adverse events.We searched for relevant studies in the databases of PubMed, Web of Science, Embase, and the Cochrane Library. The qualitative assessment of all the included articles was conducted with reference to the Newcastle-Ottawa Scale. A random-effects model was selected to perform all pooled analyses.We identified altogether 22 studies with a total of 806 symptomatic WM patients enrolled. The pooled analysis indicated that the rituximab-based combination therapy achieved an overall response rate (ORR) of 84% (95% CI: 81%-87%), a major response rate (MRR) of 71% (95% CI: 66%-75%), and a complete response rate (CRR) of 7% (95% CI: 5%-10%). Rituximab plus conventional alkylating agents-containing chemotherapy (subgroup A) yielded an ORR of 86% (95% CI: 81%-89%), an MRR of 74% (95% CI: 69%-79%), and a CRR of 8% (95% CI: 4%-14%). Rituximab plus purine analog (subgroup B) resulted in an ORR of 85% (95% CI: 79%-89%), an MRR of 74% (95% CI: 66%-81%), and a CRR of 9% (95% CI: 4%-15%). Rituximab plus proteasome inhibitor (subgroup C) resulted in an ORR of 86% (95% CI: 81%-90%), an MRR of 68% (95% CI: 58%-77%), and a CRR of 7% (95% CI: 3%-11%). Rituximab plus immunomodulatory drug (subgroup D) attained relatively lower response rates, with an ORR of 67% (95% CI: 51%-81%), an MRR of 56% (95% CI: 27%-83%), and a CRR of 5% (95% CI: 1%-12%). Common grade ≥3 hematological adverse events consisted of neutropenia (33%, 95% CI: 17%-52%), thrombocytopenia (7%, 95% CI: 3%-11%), and anemia (5%, 95% CI: 3%-9%).Rituximab in combination with an alkylating agent, purine analog, or proteasome inhibitor is highly effective with tolerable hematological toxicities for WM." @default.
• W2936758797 created "2019-04-25" @default.
• W2936758797 creator A5009055934 @default.
• W2936758797 creator A5039017005 @default.
• W2936758797 creator A5051245759 @default.
• W2936758797 creator A5051746234 @default.
• W2936758797 creator A5052530555 @default.
• W2936758797 creator A5055577592 @default.
• W2936758797 creator A5072638932 @default.
• W2936758797 creator A5084046149 @default.
• W2936758797 date "2019-04-01" @default.
• W2936758797 modified "2023-10-01" @default.
• W2936758797 title "<p>Rituximab-based combination therapy in patients with Waldenstr&ouml;m macroglobulinemia: a systematic review and meta-analysis</p>" @default.
• W2936758797 cites W1481714849 @default.
• W2936758797 cites W1499878908 @default.
• W2936758797 cites W1543117126 @default.
• W2936758797 cites W1588018827 @default.
• W2936758797 cites W1590344479 @default.
• W2936758797 cites W1949051914 @default.
• W2936758797 cites W1971884620 @default.
• W2936758797 cites W1972632013 @default.
• W2936758797 cites W1980918851 @default.
• W2936758797 cites W1991330713 @default.
• W2936758797 cites W1997911453 @default.
• W2936758797 cites W2006230035 @default.
• W2936758797 cites W2012570443 @default.
• W2936758797 cites W2022030534 @default.
• W2936758797 cites W2031944811 @default.
• W2936758797 cites W2037983836 @default.
• W2936758797 cites W2042887247 @default.
• W2936758797 cites W2043831614 @default.
• W2936758797 cites W2053682062 @default.
• W2936758797 cites W2055961991 @default.
• W2936758797 cites W2061302363 @default.
• W2936758797 cites W2078616661 @default.
• W2936758797 cites W2081047466 @default.
• W2936758797 cites W2091319225 @default.
• W2936758797 cites W2100593237 @default.
• W2936758797 cites W2109587991 @default.
• W2936758797 cites W2117582823 @default.
• W2936758797 cites W2120161945 @default.
• W2936758797 cites W2128139299 @default.
• W2936758797 cites W2128490833 @default.
• W2936758797 cites W2129783860 @default.
• W2936758797 cites W2132155614 @default.
• W2936758797 cites W2133192145 @default.
• W2936758797 cites W2135216058 @default.
• W2936758797 cites W2138189974 @default.
• W2936758797 cites W2138944846 @default.
• W2936758797 cites W2140380015 @default.
• W2936758797 cites W2148009655 @default.
• W2936758797 cites W2149103702 @default.
• W2936758797 cites W2156098321 @default.
• W2936758797 cites W2160023614 @default.
• W2936758797 cites W2160940401 @default.
• W2936758797 cites W2169205464 @default.
• W2936758797 cites W2270304543 @default.
• W2936758797 cites W2284101578 @default.
• W2936758797 cites W2310716991 @default.
• W2936758797 cites W2337139592 @default.
• W2936758797 cites W2343206351 @default.
• W2936758797 cites W246286872 @default.
• W2936758797 cites W2510982931 @default.
• W2936758797 cites W2528976200 @default.
• W2936758797 cites W2559131288 @default.
• W2936758797 cites W2559715624 @default.
• W2936758797 cites W2560708148 @default.
• W2936758797 cites W2566930362 @default.
• W2936758797 cites W2582832286 @default.
• W2936758797 cites W2589788830 @default.
• W2936758797 cites W2592772439 @default.
• W2936758797 cites W2594667125 @default.
• W2936758797 cites W2623354905 @default.
• W2936758797 cites W2744372077 @default.
• W2936758797 cites W2760907988 @default.
• W2936758797 cites W2769283949 @default.
• W2936758797 cites W2791299132 @default.
• W2936758797 cites W2530697896 @default.
• W2936758797 doi "https://doi.org/10.2147/ott.s191179" @default.
• W2936758797 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6469478" @default.
• W2936758797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31043792" @default.
• W2936758797 hasPublicationYear "2019" @default.
• W2936758797 type Work @default.
• W2936758797 sameAs 2936758797 @default.
• W2936758797 citedByCount "9" @default.
• W2936758797 countsByYear W29367587972020 @default.
• W2936758797 countsByYear W29367587972021 @default.
• W2936758797 countsByYear W29367587972022 @default.
• W2936758797 countsByYear W29367587972023 @default.
• W2936758797 crossrefType "journal-article" @default.
• W2936758797 hasAuthorship W2936758797A5009055934 @default.
• W2936758797 hasAuthorship W2936758797A5039017005 @default.
• W2936758797 hasAuthorship W2936758797A5051245759 @default.
• W2936758797 hasAuthorship W2936758797A5051746234 @default.
• W2936758797 hasAuthorship W2936758797A5052530555 @default.
• W2936758797 hasAuthorship W2936758797A5055577592 @default.
• W2936758797 hasAuthorship W2936758797A5072638932 @default.
• W2936758797 hasAuthorship W2936758797A5084046149 @default.

• next